MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

something is missing$15,125K Net increase incash, cash...$12,294K Canceled cashflow$2,831K Non-cash interestexpense$790K (758.70%↑ Y/Y)Stock-based compensation$188K (-37.95%↓ Y/Y)Change in fair value ofwarrant and derivative...$128K (12900.00%↑ Y/Y)Prepaid expenses-$124K (-114.59%↓ Y/Y)Common stock issued forservices-$100K (-100.00%↓ Y/Y)Other current assets-$47K (-4800.00%↓ Y/Y)Depreciation andamortization$34K (47.83%↑ Y/Y)Net cash used inoperating activities-$2,564K (68.61%↑ Y/Y)Effect of exchange ratechanges on cash and cash...-$267K Canceled cashflow$1,411K Net loss-$3,405K (32.60%↑ Y/Y)Tax creditreceivable$228K (-72.82%↓ Y/Y)Accrued expenses andother liabilities-$220K (90.53%↑ Y/Y)Accounts payable-$122K (-127.98%↓ Y/Y)
Cash Flow

Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics, Inc. (ALLR)

source: myfinsight.com